Clinical Trials Logo

Clinical Trial Summary

To assess the safety and tolerability for the extended wear of an experimental air-activated self adhesive patch.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01841801
Study type Interventional
Source Chattem, Inc.
Contact
Status Completed
Phase N/A
Start date October 2012
Completion date December 2012

See also
  Status Clinical Trial Phase
Completed NCT04693429 - Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+ Phase 1
Active, not recruiting NCT01703871 - Music During Diagnostic Hysteroscopy N/A
Not yet recruiting NCT00944268 - Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety Phase 3
Completed NCT01260025 - Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor Phase 1
Completed NCT01959685 - A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal Phase 1
Completed NCT01841788 - Evaluation of Experimental Heat Patch N/A
Completed NCT01158755 - Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study Phase 2
Completed NCT05633147 - Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam Phase 1
Completed NCT01981928 - A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans Phase 1
Completed NCT01954589 - Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206 Phase 1
Completed NCT01023282 - Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients Phase 1
Completed NCT02512575 - A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567. Phase 1
Recruiting NCT05142592 - IPG7236 in Patients With Advanced Solid Tumors Phase 1
Completed NCT05044949 - Study Evaluating the Safety and Tolerability of a Probioitc N/A
Completed NCT05795192 - SB17170 Phase1 Trial in Healthy Volunteer Phase 1
Completed NCT01121302 - Study to Investigate Single Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects Phase 1
Completed NCT05847218 - Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers Phase 1
Terminated NCT03503968 - TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms Phase 1/Phase 2
Completed NCT02107885 - Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants. Phase 1
Withdrawn NCT01086813 - Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043 Phase 1